3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Colorectal Neoplasms
2
Uterine Prolapse
1
Uterine Cervical Neoplasms
1
Thyroid Cancer, Papillary
1
Thymoma
1
Surgery
1
Precancerous Conditions
1
Ovarian Neoplasms
1
Neoadjuvant Chemoimmunotherapy
1
Myasthenia Gravis
1
Menstruation Disturbances
1
Lymphatic Metastasis
1
Leiomyoma
1
Invasive Breast Carcinoma
1
Gastrointenstinal Stromal Tumor (GIST)
1
Esophageal Neoplasms
1
Endometriosis
1
Endometrial Neoplasms
1
Colonic Neoplasms
1
Adenomyosis
1
Interventions
pembrolizumab
34
Cisplatin
29
Paclitaxel
15
Brachytherapy
15
Radiotherapy
14
Carboplatin
14
Bevacizumab
14
Blood Specimen Collection
13
Specimen Handling
12
Magnetic Resonance Spectroscopy
11
Colposcopy
11
Nivolumab
10
Drug Therapy
10
atezolizumab
8
Human Papillomavirus DNA Tests
8
Gemcitabine
8
lenvatinib
7
Radiation
6
Platinum
6
Biopsy
6
toripalimab
5
cemiplimab
5
Surveys and Questionnaires
5
Standard of Care
5
Radiotherapy, Intensity-Modulated
5
Practice Guidelines as Topic
5
Patient Navigation
5
Fulvestrant
5
Fluorodeoxyglucose F18
5
zimberelimab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Cervical Neoplasms
×
Robotic Surgical Procedures
×
1 year
×
Clear all
NCT07120945
2026-06-02
Embrace Gyn
Medtronic - MITG
Phase NA
Active not recruiting
70 enrolled